Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis

Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 mainly causes damage to the lung, as well as other organs and systems such as the hearts, the immune system and so on. Although the pathogen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Prolif
Main Authors: Li, Zhongwen, Niu, Shuaishuai, Guo, Baojie, Gao, Tingting, Wang, Lei, Wang, Yukai, Wang, Liu, Tan, Yuanqing, Wu, Jun, Hao, Jie
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Reviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7645923/
https://ncbi.nlm.nih.gov/pubmed/33098357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12939
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados